DDO-5936 (0~80 mg/kg; p.o.) shows effect at the high dose group.
DDO-5936 is well tolerated for the absence of serious weight loss. DDO-5936 high dose groups show that tumor cells in the xenografts decreased significantly. DDO-5936 shows limited oral efficiency.
Animal Model: |
Mice |
Dosage: |
0~80 mg/kg |
Administration: |
P.o. |
Result: |
Showed a moderate effect at the high dose group.
|